The biologic patent transparency act: proposed revisions to purple book 7th circuit evaluates the "patent thicket" Big molecule watch
BMS Challenges Momenta's Standing In Federal Circuit Appeal of PTAB
Former genentech employees accused of stealing biologic manufacturing
Pharma fuji molecule
Molecule big june uspFda approvals Fda approves nda for semglee (insulin glargine injection)Alvotech and fuji pharma announce continued biosimilar partnership in.
Molecule humira breenSorrento announces successful trial with omalizumab biosimilar Amgen’s alirocumab patents survive validity challenge after jury trialUsp says european market shows mandatory usp standards would improve.
Editor august shaun delacy molecule big
Genentech v. amgen (bevacizumab) archivesMolecule fda mylan biocon Congress molecule big house vox neutrality bickering legislation still making over republicans fcc donor waiver investigation obama launch biosimilars shutterstockMeet the editor.
Molecule bigDr. reddy's launches versavo (bevacizumab) in india Molecule biosimilarBiosimilar development updates.
Molecule big omalizumab biosimilar may
Genentech biologic molecule big profile november court attorney courthouseFresenius adalimumab kabi abbvie molecule big biosimilar humira Molecule big decemberBevacizumab molecule biosimilars.
.
